25 May Using Real World Data to Inform Clinical Research, featuring ATHN’s new Robust Health App May 25, 2022 - May 25, 2022
01 Jun Immune tolerance induction in the era of emicizumab - still the first choice for patients with hemophilia A and inhibitors Jun 1, 2022 - Jun 1, 2022
15 Jun Factor product utilization and health outcomes in patients with hemophilia A and B on extended half-life concentrates: A Canadian observational study of real-world outcomes Jun 15, 2022 - Jun 15, 2022
